REPORT HIGHLIGHT
Reporter gene assay market size was valued at USD 5,208.3 Million in 2022, expanding at a CAGR of 10.6% from 2023 to 2030.
Reporter gene assays are the most widely used cell-based assays for determining the biological role of target molecules. As a result, in living cells, researchers prefer fluorescence assays for real-time analysis of dynamic processes. This is possible owing to the availability of numerous colored reporter gene modifications, along with the fact that cell lysis or the addition of any kind of substrate is not needed for quantification. Moreover, a reporter gene is a gene type that researchers attributed to the regulatory sequence of another essential gene in cell cultures, animals, microbes, and plants.
Reporter Gene Assay Market- Market Dynamics:
- Growing preference for cell-based assays and chronic genetic disorders will drive the market growth.
- The major factor driving the growth of the reporter gene assay market is the rising preference for cell-based assays. Additionally, it is due to the rising use of reported gene assays in biomanufacturing and life science research. For studying the biochemistry and physiology of both diseased and healthy cells reporter gene assays are important experimental tools. In line with this, a lot of attention is received by reporter gene assays in terms of studying emerging developing drug therapies and infectious viruses. However, the high cost of cell biology research, a lack of modern healthcare infrastructure, and a lack of skilled researchers may limit the market growth of the reporter gene assay over the forecast period. Moreover, the increasing prevalence of infectious diseases and chronic genetic disorders in the population has boosted the demand for reporter gene assays owing to cell-based drug discovery applications. Based on this chronic disease like cancer is one of the leading causes of death across the globe. As a result, increasing incidences of rare and genetic disorders coupled with rising demand for early diagnosis and improved treatment processes are significantly driving the market growth.
Reporter Gene Assay Market- Key Insights:
- As per the analysis shared by our research analyst, the global reporter gene assay market is estimated to grow annually at a CAGR of around 10.6% over the forecast period (2023-2030)
- The reporter gene assay industry is projected to grow at a significant rate due to the rising use of reported gene assays in biomanufacturing and life science research
- Based on product type segmentation, luciferase assay was predicted to show maximum market share in the year 2022
- Based on usage segmentation, drug discovery programs was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Reporter Gene Assay Market- Segmentation Analysis:
- The global reporter gene assay market is segmented on the basis of product type, application, usage, end-use, and region.
- The market is divided into five categories based on product type: beta-galactosidase assays, luciferase assays, chloramphenicol acetyltransferase assays, beta-glucuronidase assays, fluorescent protein-related assays, and others. The luciferase assay segment is likely to possess the market share. The significant usage of assays as they enable precise measurement of signal and managing continuity of the outcomes are anticipated to increase segment growth. Additionally, these are sensitive, fast, affordable, and convenient, and display a broad linear range for detection. Furthermore, demand and preference for luciferase assays has been contributed by the dual-luciferase assay approach.
- The market is divided into two categories based on application: in-vitro studies and clinical applications. The in-vitro studies segment is attributed to the largest market share. The field of life sciences is increasing, particularly in drug metabolism analysis as the adoption of in vitro reporter gene assays. Moreover, during in vivo imaging the product has also been used.
- The market is divided into four categories based on usage: chemical biology programs, drug discovery programs, cell- & organ-based screening, and biochemical screening. The drug discovery programs segment is likely to maintain its dominance over the forecast period. For determining the drug ability of targeted compounds high-throughput assessment studies carried out which have increased in recent years. Additionally, reporter genes are used frequently in such study which is projected to boost the market growth. The protozoan parasitic transfection studies have been revolutionized by reporter gene constructs.
- The market is divided into four categories based on end use: contract research organizations (CROS), hospital & diagnostic laboratories, pharmaceutical & biotechnology companies, and academic & research institutes. The pharmaceutical & biotechnology companies segment is likely to hold the largest market revenue. In pharmaceutical product testing, cell-based assays are increasingly being used, which is a key factor driving the growth of this segment. Moreover, among pharmaceutical companies for pharma product testing iLite technology is gaining significant traction. Furthermore, the hospital & diagnostic laboratories segment is accounted to grow owing to the growing usage of reporter gene assays in clinical diagnostic applications. In line with this, various medical settings are working actively toward the same and are presently performing research on these tests' potential in non-invasive diagnostic applications.
Reporter Gene Assay Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Reporter Gene Assay Market- Competitive Landscape:
The market competition is high due to the CROs' presence in developed and developing markets. Moreover, for targeted drug discovery CROs also incorporate reporter gene assays to perform hit identification and hit-to-lead. Furthermore, market participants and governments have undertaken strategies initiatives this is expected to fuel market growth. Key players are deploying several strategies such as merger & acquisition, R&D activities, partnership, innovative product launches, and collaboration. For instance, in January 2021, Taysha Gene Therapies announced to build off a new current Good Manufacturing Practices (cGMP) gene therapy manufacturing facility in Durham, North Carolina, US to support preclinical, clinical, and commercial cGMP production of its broad gene therapy pipeline drugs.
Recent Developments:
For instance, in November 2021, Asuragen, Inc. released a new kit to find pathogenic variants in the CFTR gene. Additionally, the AmplideX® PCR/CE CFTR Kit, intended for research use only, offers broader coverage of the diverse U.S. population1,2 than any other commercially available, targeted CFTR testing assay.
Key features of the study:
- This proposed research study on reporter gene assay market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
- The report provides the client the latest up-to-date and trending insights about the reporter gene assay market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for reporter gene assay market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the reporter gene assay market
- Impact of COVID-19 on reporter gene assay market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on reporter gene assay market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the reporter gene assay market, we have also included competitive landscape and key innovator analysis for the reporter gene assay market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the reporter gene assay market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global reporter gene assay market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL REPORTER GENE ASSAY MARKET KEY PLAYERS
- Marker Gene Technologies, Inc.
- QIAGEN
- Merck KGaA
- Abcam plc.
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories
- Danaher
- Sartorius AG
- PerkinElmer Life Science
- Geno Technology Inc.
- Berthold Technologies GmbH & Co. KG
- Promega Corp.
GLOBALREPORTER GENE ASSAY MARKET, BY PRODUCT TYPE
- Beta-Galactosidase Assays
- Luciferase Assays
- Chloramphenicol Acetyltransferase Assays
- Beta-Glucuronidase Assays
- Fluorescent Protein-related Assays
- Other
GLOBAL REPORTER GENE ASSAY MARKET, BY APPLICATION
- In-vitro Studies
- Clinical Applications
GLOBAL REPORTER GENE ASSAY MARKET, BY USAGE
- Chemical Biology Programs
- Drug Discovery Programs
- Cell- & Organ-based Screening
- Biochemical Screening
GLOBAL REPORTER GENE ASSAY MARKET, BY END-USE
- Contract Research Organizations (CROs)
- Hospital & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
GLOBAL REPORTER GENE ASSAY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA